The aims of the present study were to determine if plasma GDF15 levels (i) were different in psychosis patients compared to healthy controls, (ii) associated with severity of psychotic illness, and (iii) associated with degree of metabolic comorbidity and CRP levels in the patients. Here, GDF15 is linked to psychotic disorder.